Hormone replacement therapy and heart disease prevention: experimentation trumps observation

Editorial

D B Petitti. JAMA. 1998.

. 1998 Aug 19;280(7):650-2.

doi: 10.1001/jama.280.7.650.

No abstract available

Comment in

Hormone replacement therapy for secondary prevention of coronary heart disease.
Sullivan JL. Sullivan JL. JAMA. 1999 Mar 3;281(9):795; author reply 796-7. JAMA. 1999. PMID: 10070996 No abstract available.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Heckbert SR, Weiss NS, Psaty BM. Heckbert SR, et al. JAMA. 1999 Mar 3;281(9):795-6; author reply 796-7. JAMA. 1999. PMID: 10070997 No abstract available.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Vandenbroucke JP. Vandenbroucke JP. JAMA. 1999 Mar 3;281(9):796; author reply 797. JAMA. 1999. PMID: 10070998 No abstract available.

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Hulley S, et al. JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605. JAMA. 1998. PMID: 9718051 Clinical Trial.